ATE412010T1 - Selektive peptidische agonisten des vpac2- rezeptors - Google Patents
Selektive peptidische agonisten des vpac2- rezeptorsInfo
- Publication number
- ATE412010T1 ATE412010T1 AT05755072T AT05755072T ATE412010T1 AT E412010 T1 ATE412010 T1 AT E412010T1 AT 05755072 T AT05755072 T AT 05755072T AT 05755072 T AT05755072 T AT 05755072T AT E412010 T1 ATE412010 T1 AT E412010T1
- Authority
- AT
- Austria
- Prior art keywords
- vpac2 receptor
- peptidic agonists
- selective peptidic
- selective
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57373904P | 2004-05-21 | 2004-05-21 | |
US62788004P | 2004-11-12 | 2004-11-12 | |
US65660105P | 2005-02-25 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE412010T1 true ATE412010T1 (de) | 2008-11-15 |
Family
ID=35044731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05755072T ATE412010T1 (de) | 2004-05-21 | 2005-05-19 | Selektive peptidische agonisten des vpac2- rezeptors |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080026996A1 (de) |
EP (1) | EP1756156B1 (de) |
AT (1) | ATE412010T1 (de) |
CA (1) | CA2564740A1 (de) |
DE (1) | DE602005010578D1 (de) |
WO (1) | WO2005113594A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007004116A (es) | 2004-10-08 | 2007-10-05 | Forbes Medi Tech Res Inc | Composiciones farmaceuticas de polipeptidos intestinales vasoactivos. |
US7595294B2 (en) * | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
US20090170775A1 (en) * | 2004-10-08 | 2009-07-02 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide compositions |
WO2006121588A2 (en) * | 2005-05-06 | 2006-11-16 | Bayer Pharmaceuticals Corporation | Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
CA2627716A1 (en) * | 2005-10-26 | 2007-05-03 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
JP2009528376A (ja) * | 2006-02-28 | 2009-08-06 | イーライ リリー アンド カンパニー | 選択的vpac2受容体ペプチドアゴニスト |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242563B1 (en) * | 1998-07-20 | 2001-06-05 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Peptide analogues |
RU2269354C2 (ru) * | 1999-09-28 | 2006-02-10 | Байер Корпорейшн | Агонисты рецептора-3(r3) пептида-активатора гипофизарной аденилатциклазы(расар) и способы их фармакологического применения |
PE20040677A1 (es) * | 2002-07-12 | 2004-10-29 | Bayer Pharmaceuticals Corp | Agonistas del receptor (vpac2) del peptido activante de la adenilato ciclasa hipofisaria (pacap) |
-
2005
- 2005-05-19 US US11/569,258 patent/US20080026996A1/en not_active Abandoned
- 2005-05-19 CA CA002564740A patent/CA2564740A1/en not_active Abandoned
- 2005-05-19 EP EP05755072A patent/EP1756156B1/de not_active Not-in-force
- 2005-05-19 AT AT05755072T patent/ATE412010T1/de not_active IP Right Cessation
- 2005-05-19 WO PCT/US2005/017435 patent/WO2005113594A1/en active Application Filing
- 2005-05-19 DE DE602005010578T patent/DE602005010578D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2005113594A1 (en) | 2005-12-01 |
EP1756156A1 (de) | 2007-02-28 |
CA2564740A1 (en) | 2005-12-01 |
EP1756156B1 (de) | 2008-10-22 |
DE602005010578D1 (de) | 2008-12-04 |
US20080026996A1 (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE389670T1 (de) | Selektive peptidische agonisten des vpac2- rezeptors | |
NO20082345L (no) | Selektive VPAC2 reseptorpeptidagonister | |
WO2006023356A3 (en) | Selective vpac2 receptor peptide agonists | |
ATE529442T1 (de) | Verbesserte humane interferon-moleküle und ihre verwendungen | |
WO2006097536A3 (en) | Dimeric peptide agonists of the glp-1 receptor | |
GB2436266A (en) | Modified human growth hormone | |
GB0700909D0 (en) | Novel antigen-binding polypeptides and their uses | |
WO2007101146A3 (en) | Selective vpac2 receptor peptide agonists | |
WO2007133828A3 (en) | Selective vpac2 receptor peptide agonists | |
EA200600055A1 (ru) | Агонисты рецептора меланокортина 4 (мк4 ) и их применение | |
EA200701918A1 (ru) | Белок липокалин | |
MXPA06011924A (es) | Dispositivo de liberacion continua base polimeros. | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
CY1110980T1 (el) | Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες | |
SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
WO2008079326A3 (en) | Methods for using and identifying modulators of delta-like 4 | |
ATE412010T1 (de) | Selektive peptidische agonisten des vpac2- rezeptors | |
EA200702193A1 (ru) | Гликозилирование белков | |
UA92593C2 (ru) | Лечение мастита энрофлоксацином | |
SG10201803541TA (en) | Biologically active c-terminal arginine-containing peptides | |
DE602005013650D1 (de) | Proteinhydrolysat zur behandlung von müdigkeit | |
ATE399532T1 (de) | Medizinische seife | |
CY1109803T1 (el) | Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση | |
RS53671B1 (en) | FVIII-Derived Peptides and Their Use in Tolerated Hemophiliacs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |